A
Advanced Heart and Vascular Institute of Hunterdon | Flemington, NJ
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Olpasiran
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
PARAMOUNT is a prospective randomized open-label trial testing the hypothesis that a personalized management strategy in symptomatic patients with su...
Enrolling
Coronary Artery Disease
Device: Cleerly Labs and Cleerly ISCHEMIA
TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for athero...
Enrolling
Diabetes Mellitus, Type 2
Metabolic Syndrome
Device: The Cleerly CAD Staging System
The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardi...
Enrolling
Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo
Trial sponsors
C
R
S
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems